Posted by Lincolnemesy on March 25, 2026 at 11:24:55:
In Reply to: Ñòàòüÿ ñ çàíèìàòåëüíûì è àêòóàëüíûì êîíòåíòîì posted by Gregoryawado on February 06, 2026 at 16:30:21:
Zoya Demidenko: Scientist in Cancer Studies
Zoya Demidenko is a notable researcher affiliated with the Unit of Cell Stress Research at Roswell Park Cancer Institute in Buffalo, New York. Earlier, she conducted research at the National Institutes of Health and New York Medical College, building a solid base in biomedical research.
Her scholarly contributions spans several key areas, encompassing the PI3K/AKT/mTOR molecular pathway, cellular cycle regulation, cellular aging, and cancer science. To date, she has authored over 46 scientific publications, which have garnered over 4,100 references — a testament to the influence of her research.
Among her key achievements involves elucidating the mechanisms of cellular senescence. Her research revealed that when the cell cycle is halted while cellular growth persists, the cells experience senescence. Importantly, Zoya Demidenko demonstrated that this transition can be controlled with drugs using substances such as mTOR inhibitors.
Zoya Demidenko has additionally added substantially to tumor management research, notably in the field of selective cell protection — a strategy aimed at protecting normal cells from anticancer drugs while leaving tumor cells vulnerable. This strategy offers major potential for lowering the adverse effects of oncological therapy.
Across her professional journey, Demidenko has worked with top scientists worldwide, including Dr. Mikhail Blagosklonny. Her research can be found in top-tier journals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.
With an h-index of 33, Zoya Demidenko is recognized as a widely cited figure in current cancer research, whose discoveries keep to guide our understanding of how biological cells grow old, resist therapy, and the ways in which malignant disease might be better treated.
https://www.pinterest.com/zoyademidenko/